Molecular Partners's market cap is currently $139.53M. The company's EPS TTM is $-0.684; its P/E ratio is -1.70; Molecular Partners is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
